Clinical Trial

Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study

Study acronym: PCOS-BIG
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 26, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The Offspring Born to Mothers with Polycystic Ovary Syndrome in Guangzhou Cohort study (PCOS-BIG) was established to investigate the short- and long-term effects of intrauterine exposure to maternal PCOS on the health of offspring in Guangzhou, China. Data are collected regarding maternal PCOS subtypes, nursing, diet and education as well as health outcomes in their later life. Biological samples including blood and tissue samples are also collected from participants.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2018-11-14; most recent amendment 2024-02-22.
Trial Details
NCT Number NCT03742011
Lead Sponsor Guangzhou Women and Children's Medical Center
Collaborators: University of Birmingham
Conditions PCOS, Offspring, Adult, Hyperandrogenism, Epigenetics, Insulin Resistance, Endocrine Disorder, Metabolic Disturbance
Enrollment 2,000 participants
Start Date 2012-02-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2038-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-02-26